Sagimet Biosciences (SGMT) Current Leases (2023 - 2024)
Sagimet Biosciences has reported Current Leases over the past 2 years, most recently at $116000.0 for Q3 2024.
- Quarterly results put Current Leases at $116000.0 for Q3 2024, up 12.62% from a year ago — trailing twelve months through Sep 2024 was $116000.0 (up 12.62% YoY), and the annual figure for FY2023 was $65000.0, changed.
- Current Leases for Q3 2024 was $116000.0 at Sagimet Biosciences, down from $153000.0 in the prior quarter.
- Over the last five years, Current Leases for SGMT hit a ceiling of $153000.0 in Q2 2024 and a floor of $26000.0 in Q1 2024.